Document is current

Any future updates will be listed below

Impact of immune-related adverse events on the therapeutic efficacy of pembrolizumab in urothelial carcinoma: a multicenter retrospective study using time-dependent analysis

Crossref DOI link: https://doi.org/10.1136/jitc-2021-003965

Published Online: 2022-02-24

Published Print: 2022-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark